Patents by Inventor Lan-Qing Huang

Lan-Qing Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumour rejection antigens
    Patent number: 8519109
    Abstract: Polypeptides comprising an unbroken sequence of amino acids from SEQ. ID. NO. 1 or 2, with an ability to complex with a major histocompatibility complex molecule type HLA-A2, and preferably HLA-A2.1.
    Type: Grant
    Filed: February 3, 2009
    Date of Patent: August 27, 2013
    Assignee: Ludwig Institute for Cancer Research Ltd.
    Inventors: Lan-Qing Huang, Aline van Pel, Francis Brasseur, Etienne De Plaen, Thierry Boon-Falleur
  • TUMOUR REJECTION ANTIGENS
    Publication number: 20090209034
    Abstract: Polypeptides comprising an unbroken sequence of amino acids from SEQ. ID. NO. 1 or 2, with an ability to complex with a major histocompatibility complex molecule type HLA-A2, and preferably HLA-A2.1.
    Type: Application
    Filed: February 3, 2009
    Publication date: August 20, 2009
    Applicant: Ludwig Institute for Cancer Research Ltd.
    Inventors: Lan-Qing Huang, Aline Van Pel, Francis Brasseur, Etienne De Plaen, Thierry Boon-Falleur
  • Tumor rejection antigens
    Patent number: 7547439
    Abstract: Polypeptides comprising an unbroken sequence of amino acids from SEQ ID NO: 1 or 2, with an ability to complex with a major histocompatibility complex molecule type HLA-A2, and preferably HLA-A2.1.
    Type: Grant
    Filed: November 26, 1999
    Date of Patent: June 16, 2009
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Lan-Qing Huang, Aline Van Pel, Francis Brasseur, Etienne De Plaen, Thierry Boon